HERO (A randomized, placebo-controlled trial of oxpentifylline on haemoglobin levels in patients with erythropoietin-resistant anaemia) (2007–2010)

Grant type:
Janssen-Cilag Pty Limited (Janssen-Cilag Australia)
Researchers:
  • Academic Title-Professor
    Princess Alexandra Hospital Southside Clinical Unit
    Faculty of Medicine
  • Academic Title-Professor
    Princess Alexandra Hospital Southside Clinical Unit
    Faculty of Medicine
Funded by:
Janssen-Cilag Pty Limited (Janssen-Cilag Australia)